Tumor-associated macrophages contribute to tumor progression in ovarian cancer

Frontiers in Oncology
Emily K Colvin

Abstract

Ovarian cancer is the leading cause of death in women with gynecological malignancy and improvements in current treatments are needed. As with many other solid cancers, the ovarian tumor microenvironment is emerging as a key player in tumor progression and a potential therapeutic target. The tumor microenvironment contains several non-malignant cell types that are known to contribute to tumor progression and metastasis. Included in this population of non-malignant cells are several different types of immune cells, of which tumor-associated macrophages (TAMs) are the most abundant. An increasing amount of evidence is emerging to suggest that TAMs display a unique activation profile in ovarian tumors and are able to create an immunosuppressive microenvironment, allowing tumors to evade immune detection and promoting tumor progression. Therefore, an increased understanding of how these immune cells interact with tumor cells and the microenvironment will greatly benefit the development of more effective immunotherapies to treat ovarian cancer. This review focuses on the role of TAMs in the ovarian tumor microenvironment and how they promote tumor progression.

References

Apr 1, 1991·American Journal of Obstetrics and Gynecology·J S BerekO Martínez-Maza
May 1, 1995·The Journal of Clinical Investigation·R P NegusF R Balkwill
Feb 1, 1995·Annals of Medicine·B M Kacinski
Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A SicaA Mantovani
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Feb 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R RaspolliniG L Taddei
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thorsten HagemannFrances R Balkwill
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Jan 21, 2006·Cancer Research·Claire E Lewis, Jeffrey W Pollard
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ilyssa O Gordon, Ralph S Freedman
Apr 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thorsten HagemannFrances R Balkwill
Apr 12, 2006·The Journal of Experimental Medicine·Ilona KryczekWeiping Zou
Jan 16, 2007·American Journal of Reproductive Immunology : AJRI·Rui ChenGil Mor
Jun 19, 2007·Cancer Research·Toni M Robinson-SmithAngela F Drew
Jul 11, 2007·Molecular Cancer Therapeutics·Thorsten HagemannFrances R Balkwill
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William E WinterUNKNOWN Gynecologic Oncology Group Study
Nov 27, 2007·Gynecologic Oncology·Markéta TomsováIvo Steiner
May 21, 2008·The Journal of Experimental Medicine·Thorsten HagemannFrances R Balkwill
Dec 9, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Blaise ClarkeC Blake Gilks
Feb 17, 2009·The American Journal of Pathology·Laureen S OjalvoJeffrey W Pollard
Mar 14, 2009·Nature Reviews. Immunology·Jeffrey W Pollard
Apr 21, 2009·International Journal of Cancer. Journal International Du Cancer·Dorothée DulucPascale Jeannin
Dec 19, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laureen S OjalvoJeffrey W Pollard
Apr 8, 2010·Cell·Bin-Zhi Qian, Jeffrey W Pollard
Feb 15, 2011·Cancer Biology & Therapy·Gil MorAyesha Alvero
Nov 9, 2011·Cancer Research·Hagen KulbeFrances R Balkwill
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 7, 2012·Journal of Oncology·Dong-Jun PengWeiping Zou
Jan 8, 2013·Technology in Cancer Research & Treatment·Chunyan LanJihong Liu

❮ Previous
Next ❯

Citations

Jan 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chayanon NgambenjawongSuzie H Pun
Mar 3, 2015·Gynecologic Oncology·Christina WefersStanleyson V Hato
Nov 13, 2015·Endocrine-related Cancer·Sun Wook ChoYoung Joo Park
Jul 29, 2016·Oncoimmunology·Lucia CottoneAngelo A Manfredi
Sep 17, 2015·Endocrine-related Cancer·Helen GharwanChristina M Annunziata
Jun 19, 2015·Journal of Cellular and Molecular Medicine·Jing LiXiaoming Jin
Dec 17, 2014·Frontiers in Chemistry·João ConniotTeresa S Barata
May 28, 2016·Molecular Cancer·Jamie N Frediani, Muller Fabbri
Jun 21, 2016·Journal de gynécologie, obstétrique et biologie de la reproduction·M NayamaD Vinatier
Oct 19, 2016·Gynecologic Oncology·Eric R CraigRebecca C Arend
May 15, 2015·Journal of the National Cancer Institute·Kishore B ChallagundlaMuller Fabbri
Oct 19, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Neil Johnson, John B Liao
Sep 28, 2017·Cancer Immunology, Immunotherapy : CII·Liam Friel TrembleDeclan M Soden
Jan 19, 2018·Journal of Leukocyte Biology·Leon P PradelCarola H Ries
May 11, 2019·PloS One·Michael E BregenzerGeeta Mehta
Jan 18, 2018·Expert Opinion on Drug Discovery·Elizabeth Magnotti, Wayne A Marasco
Dec 22, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luiz Antonio LupiLuiz Gustavo de Almeida Chuffa
Jan 19, 2020·Cancer Immunology, Immunotherapy : CII·Michael HaderUdo S Gaipl
Mar 10, 2020·Journal of the Chinese Medical Association : JCMA·Wen-Ling Lee, Peng-Hui Wang
Mar 21, 2020·Experimental and Therapeutic Medicine·Bo-Young KimKoanhoi Kim
Nov 17, 2017·Molecular & Cellular Proteomics : MCP·Thomas WorzfeldRolf Müller
May 30, 2019·Protein & Cell·Phei Er Saw, Er-Wei Song
Mar 13, 2020·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Mirza S BaigKishore K Wary
Aug 19, 2017·Stem Cells International·Manuel Varas-GodoySebastián E Illanes
Dec 13, 2018·Journal of Experimental & Clinical Cancer Research : CR·Kazuya KuwadaToshiyoshi Fujiwara
Sep 29, 2020·Frontiers in Pharmacology·Paige G SmithJocelyn C Reader
May 18, 2020·Cellular Oncology (Dordrecht)·Meysam YousefiAlireza Pasdar
Oct 22, 2017·The FEBS Journal·Massimiliano MazzoneAlessandra Castegna
Apr 9, 2020·Immunological Investigations·Ana Carolinne Da SilvaRosekeila Simões Nomelini
Jul 8, 2020·Cancers·Alejandra MartinezChristel Devaud
Sep 25, 2017·The FEBS Journal·Meher MajetyCarola H Ries

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
xenograft

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.